← FDA Drug Approvals (Drugs@FDA)
LOREEV XR
NDA · New Drug Application · Sponsor: ALMATICA · Approved 2021-08-27
Drug application
- FDA Application #
NDA214826- Application type
- New Drug Application
- Brand name
- LOREEV XR
- Generic name
- LORAZEPAM
- Active ingredients
- LORAZEPAM
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- ALMATICA
- Manufacturer
- Almatica Pharma LLC
- First approval
- 2021-08-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown